Evidence map›Paper›PMID 34276046›Full record

ArticleGene therapy2022

Screening for gene doping transgenes in horses via the use of massively parallel sequencing.

Jillian Maniego, Bogusia Pesko, Jocelyn Habershon-Butcher, Jim Huggett, Polly Taylor, James Scarth, Edward Ryder

Abstract read
PubMed Publisher
In one paragraph

Article in Gene therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. PCR-Based Equine Gene Doping Test for the Australian Horseracing Industry.International journal of molecular sciences · 2024
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jillian ManiegoSport and Specialised Analytical Services, LGC, Fordham, Cambridgeshire, UK.ORCID 0000-0003-0706-3285
Bogusia PeskoSport and Specialised Analytical Services, LGC, Fordham, Cambridgeshire, UK.ORCID 0000-0002-9540-204X
Jocelyn Habershon-ButcherBritish Horseracing Authority, London, UK.ORCID 0000-0002-6963-797X
Jim HuggettNational Measurement Laboratory, LGC, Teddington, Middlesex, UK.
Polly TaylorSport and Specialised Analytical Services, LGC, Fordham, Cambridgeshire, UK.
James ScarthSport and Specialised Analytical Services, LGC, Fordham, Cambridgeshire, UK.
Edward RyderSport and Specialised Analytical Services, LGC, Fordham, Cambridgeshire, UK. edward.ryder@lgcgroup.com.ORCID 0000-0002-1799-9899
Analytical Services · USBritish Horseracing Authority · GBNational Physical Laboratory · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Throughout the history of horse racing, doping techniques to suppress or enhance performance have expanded to match the technology available. The next frontier in doping, both in the equine and human sports areas, is predicted to be genetic manipulation; either by prohibited use of genome editing, or gene therapy via transgenes. By using massively-parallel sequencing via a two-step PCR method we can screen for multiple doping targets at once in pooled primer sets. This method has the advantages of high scalability through combinational indexing, and the use of reference standards with altered sequences as controls. Custom software produces transgene-specific amplicons from any Ensembl-annotated genome to facilitate rapid assay design. Additional scripts batch-process FASTQ data from experiments, automatically quality-filtering sequences and assigning hits based on discriminatory motifs. We report here our experiences in establishing the workflow with an initial 31 transgene and vector feature targets. To evaluate the sensitivity of parallel sequencing in a real-world setting, we performed an intramuscular (IM) administration of a control rAAV vector into two horses and compared the detection sensitivity between parallel sequencing and real-time qPCR. Vector was detected by all assays on both methods up to 79 h post-administration, becoming sporadic after 96 h.

Indexed as

Doping in SportsAnimalsGenetic TherapyHigh-Throughput Nucleotide SequencingHorsesReal-Time Polymerase Chain ReactionTransgenes

Identifiers

PMID34276046
OpenAlexW3183479515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.